Dexcom on Tuesday announced that its new over-the-counter continuous glucose monitor called Stelo has been cleared for use by the FDA. The new CGM is designed for patients with Type 2 diabetes who do ...
SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter ...
Dexcom on Tuesday announced that its new over-the-counter continuous glucose monitor named Stelo has been cleared for use by the U.S. Food and Drug Administration, and it will be available for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results